Hedge Fund - CQS Cayman LP
Elevance Health Inc. (ELV) NOTE 2.750%10/1
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2023 - Q1 (2023-03-31) | $0 | 0% | 0 | $475.89 |
| 2 | 2022 - Q4 (2022-12-31) | $8,055,410 | 1.05% | 1,100,000 | $507.74 |
| 3 | 2022 - Q3 (2022-09-30) | $7,142,000 | 0.83% | 1,100,000 | $478.49 |
| 4 | 2022 - Q2 (2022-06-30) | $7,455,000 | 0.8% | 1,100,000 | $494.71 |
| 5 | 2022 - Q1 (2022-03-31) | $7,598,000 | 0.52% | 1,100,000 | $457.10 |
| 6 | 2021 - Q4 (2021-12-31) | $7,158,000 | 0.44% | 1,100,000 | $420.70 |
| 7 | 2021 - Q3 (2021-09-30) | $5,753,000 | 0.32% | 1,100,000 | $380.04 |
| 8 | 2021 - Q2 (2021-06-30) | $5,885,000 | 0.32% | 1,100,000 | $382.16 |
| 9 | 2021 - Q1 (2021-03-31) | $5,537,000 | 0.34% | 1,100,000 | $321.58 |
| 10 | 2020 - Q4 (2020-12-31) | $6,291,000 | 0.38% | 1,400,000 | $306.88 |
| 11 | 2020 - Q3 (2020-09-30) | $0 | 0% | 0 | $269.07 |
| 12 | 2020 - Q2 (2020-06-30) | $7,542,000 | 0.46% | 2,050,000 | $266.78 |
| 13 | 2020 - Q1 (2020-03-31) | $7,473,000 | 0.55% | 2,350,000 | $272.52 |
| 14 | 2019 - Q4 (2019-12-31) | $10,126,000 | 0.47% | 2,400,000 | $275.19 |
| 15 | 2019 - Q3 (2019-09-30) | $8,070,000 | 0.35% | 2,400,000 | $273.99 |
| 16 | 2019 - Q2 (2019-06-30) | $9,207,000 | 0.36% | 2,350,000 | $273.16 |
| 17 | 2019 - Q1 (2019-03-31) | $18,946,000 | 0.85% | 4,750,000 | $289.21 |
| 18 | 2018 - Q4 (2018-12-31) | $19,600,000 | 1.34% | 5,400,000 | $274.98 |
| 19 | 2018 - Q3 (2018-09-30) | $17,044,000 | 0.8% | 4,500,000 | $259.59 |
| 20 | 2018 - Q2 (2018-06-30) | $0 | 0% | 0 | $231.57 |
| 21 | 2018 - Q1 (2018-03-31) | $13,680,000 | 0.63% | 4,500,000 | $234.91 |
| 22 | 2017 - Q4 (2017-12-31) | $19,282,000 | 1.22% | 6,250,000 | $212.98 |
| 23 | 2017 - Q3 (2017-09-30) | $17,639,000 | 1.18% | 6,750,000 | $190.32 |
| 24 | 2017 - Q2 (2017-06-30) | $17,466,000 | 1.2% | 6,750,000 | $179.68 |
| 25 | 2017 - Q1 (2017-03-31) | $17,861,000 | 1.35% | 7,750,000 | $159.07 |
| 26 | 2016 - Q4 (2016-12-31) | $15,477,000 | 1.22% | 7,750,000 | $133.90 |
| 27 | 2016 - Q3 (2016-09-30) | $14,228,000 | 1.19% | 8,050,000 | $129.12 |
| 28 | 2016 - Q2 (2016-06-30) | $14,865,000 | 1.31% | 8,100,000 | $136.83 |
| 29 | 2016 - Q1 (2016-03-31) | $16,061,000 | 1.6% | 8,350,000 | $133.63 |
| 30 | 2015 - Q4 (2015-12-31) | $15,986,000 | 1.1% | 8,350,000 | $137.76 |
| 31 | 2015 - Q3 (2015-09-30) | $15,618,000 | 1.3% | 8,250,000 | $150.29 |
| 32 | 2015 - Q2 (2015-06-30) | $18,607,000 | 1.12% | 8,450,000 | $159.77 |
| 33 | 2015 - Q1 (2015-03-31) | $229,973,000 | 10.82% | 110,727,000 | $142.38 |
| 34 | 2014 - Q4 (2014-12-31) | $0 | 0% | 0 | $123.57 |
| 35 | 2014 - Q3 (2014-09-30) | $134,628,000 | 7.99% | 80,490,000 | $114.70 |
| 36 | 2014 - Q2 (2014-06-30) | $117,174,000 | 7.21% | 75,990,000 | $103.04 |
| 37 | 2014 - Q1 (2014-03-31) | $13,238,000 | 1.07% | 9,000,000 | $90.44 |
| 38 | 2013 - Q4 (2013-12-31) | $6,399,000 | 0.7% | 4,700,000 | $88.85 |
The displayed share prices are average quarterly stock market prices.